Your browser doesn't support javascript.
loading
Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience.
Bekoz, Huseyin; Ozbalak, Murat; Karadurmus, Nuri; Paydas, Semra; Turker, Alev; Toptas, Tayfur; Tuglular, Tülin Firatli; Altuntas, Fevzi; Cakar, Merih Kizil; Sonmez, Mehmet; Gulbas, Zafer; Demir, Nazli; Kaynar, Leylagul; Yildirim, Rahsan; Karadogan, Ihsan; Arat, Mutlu; Kapucu, Irem; Aslan, Nevin Alayvaz; Ozkocaman, Vildan; Turgut, Mehmet; Yuksel, Meltem Kurt; Ozcan, Muhit; Hacioglu, Sibel Kabukcu; Barista, Ibrahim; Demirkaya, Metin; Saydam, Guray; Toprak, Selami K; Yilmaz, Mehmet; Demirkol, Onur; Ferhanoglu, Burhan.
Afiliação
  • Bekoz H; Division of Hematology, Department of Internal Medicine, Medipol University, Istanbul, Istanbul, Turkey.
  • Ozbalak M; Division of Hematology, Department of Internal Medicine, Istanbul University Istanbul Medical Faculty, Istanbul, Turkey.
  • Karadurmus N; Division of Medical Oncology, Department of Internal Medicine, Gulhane Research and Training Hospital, Ankara, Turkey.
  • Paydas S; Division of Medical Oncology, Department of Internal Medicine, Cukurova University, Adana, Turkey.
  • Turker A; Division of Medical Oncology, Department of Internal Medicine, Hacettepe University, Ankara, Turkey.
  • Toptas T; Division of Hematology, Department of Internal Medicine, Marmara University, Istanbul, Turkey.
  • Tuglular TF; Division of Hematology, Department of Internal Medicine, Marmara University, Istanbul, Turkey.
  • Altuntas F; Division of Hematology, Dr. Abdurrahman Yurtaslan Ankara Oncology Research and Training Hospital, Ankara, Turkey.
  • Cakar MK; Division of Hematology, Dr. Abdurrahman Yurtaslan Ankara Oncology Research and Training Hospital, Ankara, Turkey.
  • Sonmez M; Division of Hematology, Department of Internal Medicine, Karadeniz Technical University, Trabzon, Turkey.
  • Gulbas Z; Division of Hematology, Anadolu Medical Center, Izmit, Turkey.
  • Demir N; Division of Hematology, Department of Internal Medicine, Gazi Yasargil Research and Training Hospital, Diyarbakir, Turkey.
  • Kaynar L; Division of Hematology, Department of Internal Medicine, Erciyes University, Kayseri, Turkey.
  • Yildirim R; Division of Hematology, Department of Internal Medicine, Ataturk University, Erzurum, Turkey.
  • Karadogan I; Division of Hematology, Medstar Antalya Hospital, Antalya, Turkey.
  • Arat M; Division of Hematology, Florence Nighthingale Hospital, Istanbul, Turkey.
  • Kapucu I; Department of Internal Medicine, Koc University School of Medicine, Istanbul, Turkey.
  • Aslan NA; Division of Hematology, Dr. Ersin Arslan Research and Training Center, Gaziantep, Turkey.
  • Ozkocaman V; Division of Hematology, Department of Internal Medicine, Uludag University, Bursa, Turkey.
  • Turgut M; Division of Hematology, Department of Internal Medicine, Ondokuz Mayis University, Samsun, Turkey.
  • Yuksel MK; Division of Hematology, Department of Internal Medicine, Ankara University, Ankara, Turkey.
  • Ozcan M; Division of Hematology, Department of Internal Medicine, Ankara University, Ankara, Turkey.
  • Hacioglu SK; Division of Hematology, Department of Internal Medicine, Pamukkale University, Denizli, Turkey.
  • Barista I; Division of Medical Oncology, Department of Internal Medicine, Hacettepe University, Ankara, Turkey.
  • Demirkaya M; Division of Medical Oncology, Department of Pediatrics, Uludag University, Bursa, Turkey.
  • Saydam G; Division of Hematology, Department of Internal Medicine, Ege University, Izmir, Turkey.
  • Toprak SK; Division of Hematology, Department of Internal Medicine, Ankara University, Ankara, Turkey.
  • Yilmaz M; Division of Hematology, Department of Internal Medicine, Gaziantep University, Gaziantep, Turkey.
  • Demirkol O; Department of Nuclear Medicine, Koc University School of Medicine, Istanbul, Turkey.
  • Ferhanoglu B; Division of Hematology, Department of Internal Medicine, Koc University School of Medicine and V.K.V. American Hospital, Istanbul, Turkey. bferhan@gmail.com.
Ann Hematol ; 99(11): 2565-2576, 2020 Nov.
Article em En | MEDLINE | ID: mdl-32507911
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Nivolumabe Tipo de estudo: Observational_studies / Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Hematol Assunto da revista: HEMATOLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Turquia País de publicação: Alemanha
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Nivolumabe Tipo de estudo: Observational_studies / Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Hematol Assunto da revista: HEMATOLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Turquia País de publicação: Alemanha